List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
1.2 Global Peripheral Intervention Drug-Eluting Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume for the Year 2017-2028
1.3 United States Peripheral Intervention Drug-Eluting Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Peripheral Intervention Drug-Eluting Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Peripheral Intervention Drug-Eluting Devices Sales in Volume for the Year 2017-2028
1.4 Peripheral Intervention Drug-Eluting Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Peripheral Intervention Drug-Eluting Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Peripheral Intervention Drug-Eluting Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Peripheral Intervention Drug-Eluting Devices Market Dynamics
1.5.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
1.5.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
1.5.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
1.5.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Peripheral Intervention Drug-Eluting Devices Market Segment by Type
2.1.1 Drug-Eluting Balloons
2.1.2 Drug-Eluting Stents
2.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type
2.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Peripheral Intervention Drug-Eluting Devices Market Size by Type
2.3.1 United States Peripheral Intervention Drug-Eluting Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Peripheral Intervention Drug-Eluting Devices Market Segment by Application
3.1.1 Plain Old Balloon Angioplasty (POBA)
3.1.2 Percutaneous Transluminal Angioplasty (PTA)
3.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Peripheral Intervention Drug-Eluting Devices Market Size by Application
3.3.1 United States Peripheral Intervention Drug-Eluting Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Peripheral Intervention Drug-Eluting Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Peripheral Intervention Drug-Eluting Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Peripheral Intervention Drug-Eluting Devices Competitor Landscape by Company
4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Company
4.1.1 Top Global Peripheral Intervention Drug-Eluting Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturer (2017-2022)
4.2 Global Peripheral Intervention Drug-Eluting Devices Concentration Ratio (CR)
4.2.1 Peripheral Intervention Drug-Eluting Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Peripheral Intervention Drug-Eluting Devices in 2021
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Peripheral Intervention Drug-Eluting Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
4.3.3 Date of International Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Peripheral Intervention Drug-Eluting Devices Market Size by Company
4.5.1 Top Peripheral Intervention Drug-Eluting Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Peripheral Intervention Drug-Eluting Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Peripheral Intervention Drug-Eluting Devices Sales by Players (2020, 2021 & 2022)
5 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region
5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Peripheral Intervention Drug-Eluting Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Peripheral Intervention Drug-Eluting Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Region: 2017-2022
5.3.2 Global Peripheral Intervention Drug-Eluting Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028
6.1.2 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Medtronic plc
7.1.1 Medtronic plc Corporation Information
7.1.2 Medtronic plc Description and Business Overview
7.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
7.1.5 Medtronic plc Recent Development
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Corporation Information
7.2.2 Boston Scientific Corporation Description and Business Overview
7.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
7.2.5 Boston Scientific Corporation Recent Development
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporation Information
7.3.2 Abbott Laboratories Description and Business Overview
7.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered
7.3.5 Abbott Laboratories Recent Development
7.4 Cardinal Health
7.4.1 Cardinal Health Corporation Information
7.4.2 Cardinal Health Description and Business Overview
7.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered
7.4.5 Cardinal Health Recent Development
7.5 B. Braun Melsungen AG
7.5.1 B. Braun Melsungen AG Corporation Information
7.5.2 B. Braun Melsungen AG Description and Business Overview
7.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered
7.5.5 B. Braun Melsungen AG Recent Development
7.6 Biosensors International Group Ltd.
7.6.1 Biosensors International Group Ltd. Corporation Information
7.6.2 Biosensors International Group Ltd. Description and Business Overview
7.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered
7.6.5 Biosensors International Group Ltd. Recent Development
7.7 C.R. Bard, Inc.
7.7.1 C.R. Bard, Inc. Corporation Information
7.7.2 C.R. Bard, Inc. Description and Business Overview
7.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered
7.7.5 C.R. Bard, Inc. Recent Development
7.8 Abbott
7.8.1 Abbott Corporation Information
7.8.2 Abbott Description and Business Overview
7.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered
7.8.5 Abbott Recent Development
7.9 The Lubrizol Corporation
7.9.1 The Lubrizol Corporation Corporation Information
7.9.2 The Lubrizol Corporation Description and Business Overview
7.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
7.9.5 The Lubrizol Corporation Recent Development
7.10 Terumo Corporation
7.10.1 Terumo Corporation Corporation Information
7.10.2 Terumo Corporation Description and Business Overview
7.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
7.10.5 Terumo Corporation Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis
8.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Peripheral Intervention Drug-Eluting Devices Distributors
8.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process
8.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing
8.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
8.4.2 Peripheral Intervention Drug-Eluting Devices Distributors
8.5 Peripheral Intervention Drug-Eluting Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
